Valuation Stryker Corporation Mexican S.E.
Stocks
SYK *
US8636671013
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Mexican S.E.
19/08/2026
|
5-day change | 1st Jan Change | ||
| 5,784.37 MXN | -0.48% |
|
-0.48% | -9.62% |
| 08-26 | Boston Scientific Says Cyberattack Disrupting Global Operations -- Update | DJ |
| 08-26 | Boston Scientific Says Cyberattack Disrupting Global Operations | DJ |
Company Valuation: Stryker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 100,882 | 92,522 | 113,776 | 137,257 | 134,410 | 123,557 | - | - |
| Change | - | -8.29% | 22.97% | 20.64% | -2.07% | -8.08% | - | - |
| Enterprise Value (EV) 1 | 110,335 | 102,451 | 121,655 | 144,952 | 146,258 | 132,682 | 129,445 | 126,067 |
| Change | - | -7.14% | 18.74% | 19.15% | 0.9% | -9.28% | -2.44% | -2.61% |
| P/E | 51.3x | 39.6x | 36.3x | 46.4x | 41.8x | 25x | 21.8x | 19.3x |
| PBR | 6.79x | 5.56x | 6.11x | 6.65x | 5.99x | 4.69x | 4.05x | 3.48x |
| PEG | - | 2.1x | 1.1x | -7.81x | 5.07x | 0.5x | 1.5x | 1.5x |
| Capitalization / Revenue | 5.9x | 5.02x | 5.55x | 6.07x | 5.35x | 4.53x | 4.16x | 3.86x |
| EV / Revenue | 6.45x | 5.55x | 5.93x | 6.42x | 5.82x | 4.86x | 4.36x | 3.94x |
| EV / EBITDA | 23.2x | 21.5x | 22.7x | 23.6x | 20.7x | 16.7x | 15.1x | 13.3x |
| EV / EBIT | 25.2x | 23.4x | 24.6x | 25.4x | 22.2x | 18.2x | 16.1x | 14.2x |
| EV / FCF | 40.3x | 50.3x | 39.2x | 41.6x | 34.1x | 34.4x | 25.7x | 21.7x |
| FCF Yield | 2.48% | 1.99% | 2.55% | 2.41% | 2.93% | 2.91% | 3.89% | 4.62% |
| Dividend per Share 2 | 2.585 | 2.835 | 3.05 | 3.24 | 3.4 | 3.6 | 3.832 | 4.118 |
| Rate of return | 0.97% | 1.16% | 1.02% | 0.9% | 0.97% | 1.12% | 1.19% | 1.28% |
| EPS 2 | 5.21 | 6.17 | 8.25 | 7.76 | 8.4 | 12.88 | 14.78 | 16.66 |
| Distribution rate | 49.6% | 45.9% | 37% | 41.8% | 40.5% | 28% | 25.9% | 24.7% |
| Net sales 1 | 17,108 | 18,449 | 20,498 | 22,595 | 25,116 | 27,295 | 29,675 | 31,990 |
| EBITDA 1 | 4,753 | 4,755 | 5,348 | 6,142 | 7,064 | 7,944 | 8,592 | 9,464 |
| EBIT 1 | 4,382 | 4,384 | 4,955 | 5,715 | 6,603 | 7,296 | 8,065 | 8,907 |
| Net income 1 | 1,994 | 2,358 | 3,165 | 2,993 | 3,246 | 4,942 | 5,746 | 6,398 |
| Net Debt 1 | 9,453 | 9,929 | 7,879 | 7,695 | 11,848 | 9,125 | 5,888 | 2,511 |
| Reference price 2 | 267.42 | 244.49 | 299.46 | 360.05 | 351.47 | 322.12 | 322.12 | 322.12 |
| Nbr of stocks (in thousands) | 377,240 | 378,430 | 379,938 | 381,216 | 382,424 | 383,573 | - | - |
| Announcement Date | 27/01/22 | 31/01/23 | 30/01/24 | 28/01/25 | 29/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.6x | 4.97x | 17.07x | 1.09% | 126B | |
| 18.26x | 2.33x | 8.99x | 2.8% | 12.24B | |
| -223.23x | 15.16x | 1799.45x | -.--% | 10.65B | |
| 21.64x | 10.2x | 17.58x | 1.87% | 4.21B | |
| 27.6x | - | - | - | 2.77B | |
| -1433.87x | 1.69x | 7.93x | -.--% | 1.79B | |
| 17.72x | 4.78x | 9.34x | 3.46% | 1.66B | |
| Average | -220.90x | 6.52x | 310.06x | 1.54% | 22.82B | |
| Weighted average by Cap. | -8.01x | 5.55x | 137.13x | 1.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SYK Stock
- SYK * Stock
- Valuation Stryker Corporation
Select your edition
All financial news and data tailored to specific country editions
